Pharmacogenetics: Personalized Medicine for the Future
In a this episode of the podcast "Self Funded" hosted by Spencer Smith, entrepreneur Nick Glimcher shared his journey from the world of commercial real estate to the healthcare industry.
Glimcher's story highlights the importance of adaptability and seizing opportunities in different industries. He emphasizes the link between powerlifting and entrepreneurship, both requiring consistent effort and commitment for success.
One of the key challenges in the healthcare industry, as discussed in the episode, is the complex landscape of insurance companies and payment issues. These challenges can be daunting and hinder the delivery of quality care. However, Glimcher believes that precision medicine holds the key to overcoming these challenges and revolutionizing healthcare.
Precision medicine is an innovative approach that provides detailed and targeted care based on an individual's genetic makeup. Glimcher explains that precision medicine is the future of healthcare, with pharmacogenetics playing a crucial role in personalizing treatment plans.
Pharmacogenetics is the science of determining which drugs work for an individual and which do not. While the science has been commercially viable since 2010, its widespread usage has been limited due to applicability issues.
To address this issue, Glimcher's company, Blue Genes, has developed a software tool called The Blue Genes Solution. This tool aims to make pharmacogenetic data actionable in clinical settings. By integrating with pharmacy benefit managers (PBMs) and electronic medical records (EMRs), Blue Genes simplifies the interpretation of pharmacogenetic reports and provides instantaneous notifications to healthcare providers, ensuring that prescriptions are genetically efficacious.
Cost mitigation in healthcare is a pressing issue that requires innovative solutions, such as precision medicine, and bipartisan support. Glimcher highlights the importance of government involvement in pushing for coverage determinations and legislation related to pharmacogenetics. He believes that there is bipartisan support for healthcare reform because humanity and caring are not political issues but fundamental aspects of being human.
The episode also touches on the challenges faced by healthcare providers in adopting technology. Healthcare has been the last sector to embrace technological advancements, despite its critical role in keeping people alive and healthy. Glimcher emphasizes the need to make it easy for providers to integrate new technologies ethically, as they are motivated to provide the best care for their patients.
In conclusion, the episode of "Self Funded" featuring Nick Glimcher sheds light on the intersection of entrepreneurship, healthcare challenges, and precision medicine innovations. Glimcher's entrepreneurial journey and insights highlight the importance of adaptability and consistent effort in achieving success. The challenges in the healthcare industry, particularly with insurance companies and payment issues, can be overcome through precision medicine and the integration of pharmacogenetic data. The efforts of companies like Blue Genes are aimed at improving clinical outcomes and mitigating the rising costs in healthcare. With bipartisan support and a focus on humanity and caring, the future of healthcare looks promising.
Chapters:
00:01:22 Nick Glimcher's Journey of Adaptability and Opportunity
00:04:41 The Importance of Consistent Effort in Powerlifting
00:08:13 Insurance Payment Challenges in Healthcare
00:12:08 Pharmacogenetics: Personalized Medicine
00:18:00 Overcoming Limitations of Pharmacogenetic Testing
00:27:42 Genetic Makeup's Impact on Drug Effectiveness
00:32:07 Transforming Healthcare with Niche Data Analysis
00:46:02 Precision Medicine for Cost Mitigation in Healthcare